Application of Photon Therapy Instrument Combined With Ultrasonic Debridement in Senile Third and… (NCT07383519) | Clinical Trial Compass
CompletedNot Applicable
Application of Photon Therapy Instrument Combined With Ultrasonic Debridement in Senile Third and Fourth Stage Pressure Injuries
China118 participantsStarted 2023-05-01
Plain-language summary
These findings support the integrated use of ultrasonic debridement and photon therapy as a beneficial treatment strategy for advanced pressure injuries in elderly patients, demonstrating its value in improving both clinical results and overall patient well-being.
Who can participate
Age range55 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* age 55 years or older
* a patient who is fully conscious (i.e., no disturbance of consciousness such as drowsiness, lethargy, or delirium; able to accurately answer questions about time, place, and person orientation; and capable of clear communication to express needs or understand study-related instructions)
* patients with pressure injury were diagnosed with stage 3 or 4 pressure injury in accordance with the staging criteria of pressure injury published by the National Pressure Injury Advisory Panel (NPUAP).
Exclusion Criteria:
* poor blood glucose control (HbA1c \> 7.0%)
* patients allergic to red-and-blue light
* mental abnormalities who cannot cooperate with treatment
* patients with advanced malignancies, terminal patients, patients with cachexia, and patients with severe obesity
* severe complications: severe malnutrition, severe diseases of the lungs, liver, kidneys, and cardiovascular system
* patients undergoing other treatments, such as Chinese medicine treatment, negative pressure aspiration therapy, platelet-rich therapy
* who were unwilling to participate in the study. All participants signed a written informed consent form before the study began.
What they're measuring
1
Proportion of Participants with Complete Wound Healing
Timeframe: Assessed at 6 months post-randomization.